·            Francis Kalush, Network Leader for the Diagnostics (In vivo and In Vitro) and Personalized Medicine Network, FDA

·            Alain van Gool, Head Molecular Profiling, Translational Medicine Research Centre, Merck Research Laboratories, MSD, Singapore

·            Neil French, Senior Scientific Operations Manager, MRC Centre for Drug Safety Science, Department of Pharmacology & Therapeutics, The University of Liverpool

·            Mark Jones, Associate Director Molecular Biomarkers, Global Exploratory Development, UCB New Medicines

·            Miro Venturi, Senior Biomarker & Experimental Medicine Leader, Roche Pharma Development

·            Mike Lau, Principal Clinical Development Scientist, GSK Oncology

·            Gary Coulton, Director St. George's Medical Biomics Centre, St. George', University of London

·            Chris Chamberlain, Medical Director Personalised Medicine, AstraZeneca

·            Steve Furlong, Safety Science Lead and Senior Director, AstraZeneca

·            Samila Mihindukulasuriya, Senior. Contract Analyst, Biomarkers, GSK

·            Iain Kilty, Director Allergy & Respiratory Research Unit, Pfizer            

·            Matt Squires, Associate Director Translational Biology, Astex Therapeutics

·            Ian Wilson, Senior Principal Scientist, Dept. of Drug Metabolism and Pharmacokinetics, AstraZeneca

·            Patricia Hurley, Head of Project Management and Biomarkers Division, ERA Consulting (UK) Ltd

·            Samual Murray, President, Greek Society of Molecular Oncology (ElEMO), Professor University of Ioannina Cancer Biobank

·            Michael Shi, Director and Biomarker Project Leader of Exploratory Oncology Development, Novartis

·            Simon Westbrook, Head of in Vivo Pharmacology, Biomarkers, Pfizer

·            Dominic Eisinger, Director of Strategic Development, Rules-Based Medicine, Inc

Delegates will benefit from:

- An executive format providing intimate interaction with industry peers’ ideas and experiences through case study presentations and panel discussions

- Networking opportunities and sharing ideas with other senior biomarker practitioners

- Pre-scheduled one-to-one meetings between you and solution providers will provide you with an opportunity to forge partnerships and discover solutions

- Post event follow up offering all documentation from the meeting and re-booking discounts

- Tailor-made agenda – hand pick any conference and panel sessions you wish to attend